|
Note
9 Subsequent Events
Pursuant
to the executive compensation package approved by our board of directors on November 20, 2018:
| |
● |
On January 2, 2019, the Company granted 150,000
and 50,000 restricted stock units with a January 2, 2019 grant date, to Danny Schoening and Karen Hawkins, respectively, vesting
as of January 1 each year subsequent to the grant date over a three year period at a rate of 34% in year one, and 33% each
year thereafter. The stock price at grant date was $1.32 per share. The Company will amortize the grant date fair market value
of $264 thousand to stock compensation expense on a straight line basis across the three year vesting period beginning on
January 2, 2019. |
| |
● |
Effective as of January 1, 2019, Danny Schoening,
CEO and Karen Hawkins, CFO received an 8% salary increase. |
On
January 7, 2019, the Company issued 55,565 common shares the three directors and officers, net of tax withholding, in settlement
of 82,500 restricted stock units which vested on January 1, 2019.
|